BACKGROUND: The metabolic implications of intermuscular adipose tissue (IMAT) are poorly understood compared to those of visceral adipose tissue (VAT) even though the absolute quantities of both depots are similar in many individuals. OBJECTIVE: The aim was to determine the independent relationship between whole-body IMAT and cardiovascular risk factor parameters. DESIGN: Whole body magnetic resonance imaging (MRI) was used to quantify total skeletal muscle (SM), total adipose tissue (TAT) of which IMAT, defined as the AT visible by MRI within the boundary of the muscle fascia, is a sub-component. Fasting serum measures (n=262) of glucose, total cholesterol (T-Chol), high-density lipoprotein cholesterol (HDL-Chol), triglycerides (TG), protein bound glucose (PBG, n=206) and insulin (n=119) were acquired in healthy African-American (AA, n=78) and Caucasian (Ca, n=109) women (body mass index (BMI) 26.5+/-5.7 kg/m(2); 44.4+/-16.4 years) and men (39 AA, 62 Ca; BMI 25.6+/-3.5 kg/m(2); 45.6+/-17.4 years). General linear models identified the independent effects of IMAT after covarying for SM, VAT, TAT, race, sex and two-way interactions. RESULTS: Significant independent associations were observed for IMAT with glucose (P<0.001), PBG (P<0.001) and T-Chol (P<0.05). The association of IMAT with cholesterol differed by race in such a manner that for a unit increase in IMAT, T-Chol increased more rapidly in Ca compared to AA (P<0.05). TG, HDL-Chol and insulin had no independent association with IMAT. CONCLUSION: The strong independent associations of IMAT with fasting glucose and PBG suggest that IMAT may be related to glucose metabolism; however, IMAT is also associated with T-Chol in Ca.
BACKGROUND: The metabolic implications of intermuscular adipose tissue (IMAT) are poorly understood compared to those of visceral adipose tissue (VAT) even though the absolute quantities of both depots are similar in many individuals. OBJECTIVE: The aim was to determine the independent relationship between whole-body IMAT and cardiovascular risk factor parameters. DESIGN: Whole body magnetic resonance imaging (MRI) was used to quantify total skeletal muscle (SM), total adipose tissue (TAT) of which IMAT, defined as the AT visible by MRI within the boundary of the muscle fascia, is a sub-component. Fasting serum measures (n=262) of glucose, total cholesterol (T-Chol), high-density lipoprotein cholesterol (HDL-Chol), triglycerides (TG), protein bound glucose (PBG, n=206) and insulin (n=119) were acquired in healthy African-American (AA, n=78) and Caucasian (Ca, n=109) women (body mass index (BMI) 26.5+/-5.7 kg/m(2); 44.4+/-16.4 years) and men (39 AA, 62 Ca; BMI 25.6+/-3.5 kg/m(2); 45.6+/-17.4 years). General linear models identified the independent effects of IMAT after covarying for SM, VAT, TAT, race, sex and two-way interactions. RESULTS: Significant independent associations were observed for IMAT with glucose (P<0.001), PBG (P<0.001) and T-Chol (P<0.05). The association of IMAT with cholesterol differed by race in such a manner that for a unit increase in IMAT, T-Chol increased more rapidly in Ca compared to AA (P<0.05). TG, HDL-Chol and insulin had no independent association with IMAT. CONCLUSION: The strong independent associations of IMAT with fasting glucose and PBG suggest that IMAT may be related to glucose metabolism; however, IMAT is also associated with T-Chol in Ca.
Authors: C Weyer; T Funahashi; S Tanaka; K Hotta; Y Matsuzawa; R E Pratley; P A Tataranni Journal: J Clin Endocrinol Metab Date: 2001-05 Impact factor: 5.958
Authors: L O Ohlson; B Larsson; K Svärdsudd; L Welin; H Eriksson; L Wilhelmsen; P Björntorp; G Tibblin Journal: Diabetes Date: 1985-10 Impact factor: 9.461
Authors: Bret H Goodpaster; Shanthi Krishnaswami; Helaine Resnick; David E Kelley; Catherine Haggerty; Tamara B Harris; Ann V Schwartz; Steven Kritchevsky; Anne B Newman Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: A H Kissebah; N Vydelingum; R Murray; D J Evans; A J Hartz; R K Kalkhoff; P W Adams Journal: J Clin Endocrinol Metab Date: 1982-02 Impact factor: 5.958
Authors: T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki Journal: Nat Med Date: 2001-08 Impact factor: 53.440
Authors: Rebecca Scherzer; Wei Shen; Steven B Heymsfield; Cora E Lewis; Donald P Kotler; Mark Punyanitya; Peter Bacchetti; Michael G Shlipak; Carl Grunfeld Journal: Obesity (Silver Spring) Date: 2010-06-10 Impact factor: 5.002
Authors: Iva Miljkovic; Jane A Cauley; Moira A Petit; Kristine E Ensrud; Elsa Strotmeyer; Yahtyng Sheu; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Lewis H Kuller; Kimberly A Faulkner; Joseph M Zmuda Journal: J Clin Endocrinol Metab Date: 2009-05-19 Impact factor: 5.958
Authors: Stephan Sachs; Simona Zarini; Darcy E Kahn; Kathleen A Harrison; Leigh Perreault; Tzu Phang; Sean A Newsom; Allison Strauss; Anna Kerege; Jonathan A Schoen; Daniel H Bessesen; Thomas Schwarzmayr; Elisabeth Graf; Dominik Lutter; Jan Krumsiek; Susanna M Hofmann; Bryan C Bergman Journal: Am J Physiol Endocrinol Metab Date: 2019-01-08 Impact factor: 4.310
Authors: Robert M Blew; Vinson R Lee; Jennifer W Bea; Megan C Hetherington-Rauth; Jean-Phillipe Galons; Maria I Altbach; Timothy G Lohman; Scott B Going Journal: J Clin Densitom Date: 2018-03-23 Impact factor: 2.617
Authors: Carrie A Karvonen-Gutierrez; Qing Peng; Mark Peterson; Kate Duchowny; Bin Nan; Sioban Harlow Journal: Age Ageing Date: 2018-09-01 Impact factor: 10.668
Authors: Pamela U Freda; Wei Shen; Steven B Heymsfield; Carlos M Reyes-Vidal; Eliza B Geer; Jeffrey N Bruce; Dympna Gallagher Journal: J Clin Endocrinol Metab Date: 2008-03-18 Impact factor: 5.958